Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Asparagine synthetase pseudogene 1 (ENSG00000288690) is classified as a pseudogene, meaning it is a nonfunctional segment of genomic DNA that resembles the functional asparagine synthetase gene but does not encode a protein product. Pseudogenes like ASNSP1 can share sequence similarity with their parent gene, but due to mutations such as frameshifts or premature stop codons, they do not produce active proteins. While pseudogenes can sometimes be transcribed into RNA, they generally lack biological activity and are not considered therapeutic targets or biomarkers for disease. In summary, ENSG00000288690 is not a functional or druggable target but rather a nonfunctional genomic remnant related to the asparagine synthetase gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Asparagine synthetase pseudogene 1 (ASNSP1).